Literature DB >> 7477381

Involvement of Ral GTPase in v-Src-induced phospholipase D activation.

H Jiang1, J Q Luo, T Urano, P Frankel, Z Lu, D A Foster, L A Feig.   

Abstract

An early response to the tyrosine kinase activity of v-Src is an increase in phospholipase D (PLD) activity, which leads to the generation of biologically active lipid second messengers, including phosphatidic acid, lysophosphatidic acid and diacylglycerol. We have recently demonstrated that v-Src-induced PLD activity is mediated by Ras, although Ras involvement was indirect, requiring a cytosolic factor for PLD activation. Ras interacts with and activates Ral-GDS, the exchange factor responsible for the activation of Ral GTPases. Here we report that this newly identified Ras/Ral signalling pathway mediates PLD activation by v-Src. PLD activity could be precipitated from v-Src-transformed cell lysates with immobilized RalA protein and with an anti-Ral antibody. A mutation to the region of RalA analogous to the 'effector domain' of Ras did not reduce the ability of RalA to complex with PLD, although deletion of a Ral-specific amino-terminal region did. Overexpression of RalA potentiated PLD activation by v-Src, and expression of dominant negative RalA mutants inhibited both v-Src- and v-Ras-induced PLD activity. Thus RalA is involved in the tyrosine kinase activation of PLD through its unique N terminus, and that PLD is a downstream target of a Ras/Ral GTPase cascade.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477381     DOI: 10.1038/378409a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  75 in total

1.  Endocytosis and vesicular trafficking of immune complexes and activation of phospholipase D by the human high-affinity IgG receptor requires distinct phosphoinositide 3-kinase activities.

Authors:  D J Gillooly; A J Melendez; A R Hockaday; M M Harnett; J M Allen
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

2.  Regulation of Ras signaling specificity by protein kinase C.

Authors:  G Rusanescu; T Gotoh; X Tian; L A Feig
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

3.  Low-density lipoprotein activates the small GTPases Rap1 and Ral in human platelets.

Authors:  C M Hackeng; B Franke; I A Relou; G Gorter; J L Bos; H J van Rijn ; J W Akkerman
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

4.  Ral-specific guanine nucleotide exchange factor activity opposes other Ras effectors in PC12 cells by inhibiting neurite outgrowth.

Authors:  T Goi; G Rusanescu; T Urano; L A Feig
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

5.  Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB.

Authors:  D O Henry; S A Moskalenko; K J Kaur; M Fu; R G Pestell; J H Camonis; M A White
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

6.  Regulation of phospholipase D from human hepatocarcinoma cell line by purine nucleotides and protein kinase A.

Authors:  Y Huang; X Y Zhang; F Liu; H L Chen
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

7.  Regulation of the Forkhead transcription factor AFX by Ral-dependent phosphorylation of threonines 447 and 451.

Authors:  N D De Ruiter; B M Burgering; J L Bos
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

8.  Elevated phospholipase D activity in H-Ras- but not K-Ras-transformed cells by the synergistic action of RalA and ARF6.

Authors:  Lizhong Xu; Paul Frankel; Desmond Jackson; Thuy Rotunda; Rita L Boshans; Crislyn D'Souza-Schorey; David A Foster
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

9.  RalA activation at nascent lamellipodia of epidermal growth factor-stimulated Cos7 cells and migrating Madin-Darby canine kidney cells.

Authors:  Akiyuki Takaya; Yusuke Ohba; Kazuo Kurokawa; Michiyuki Matsuda
Journal:  Mol Biol Cell       Date:  2004-03-19       Impact factor: 4.138

Review 10.  Regulation of TOR by small GTPases.

Authors:  Raúl V Durán; Michael N Hall
Journal:  EMBO Rep       Date:  2012-02-01       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.